Background glaucoma Shape Background glaucoma Shape Background glaucoma Shape
Grants > Insights Into a Naturally Occurring Glaucoma Model Updated On: Jan. 23, 2025
National Glaucoma Research Grant

Insights Into a Naturally Occurring Glaucoma Model

Predicting Outcomes & Other Treatment Innovations
Amanda Melin, PhD

Principal Investigator

Amanda Melin, PhD

University of Calgary

Calgary, Alberta, Canada

About the Research Project

Program

National Glaucoma Research

Award Type

Standard

Award Amount

$197,696

Active Dates

March 01, 2021 - February 28, 2024

Grant ID

G2020047

Co-Principal Investigator(s)

James Higham, PhD, University of Calgary

Goals

By leveraging access to a large, existing sample of fresh eye tissues, we examine genes expressed, their sequences, and the metabolites that are present in individuals with and without naturally-occurring glaucoma in a closely related animal model. These data are essentially impossible to obtain for humans and provide a direct way to probe the biological functions that are impacted by glaucoma, along with genetic risk factors. These data have large promise to guide genetic screening panels used in diagnosis and prognosis of glaucoma in humans, and to identify molecules in our blood that can be used for early detection and treatment.

Summary

The goal of our project is to understand genetic and metabolic differences in ocular tissues of individuals with and without naturally occurring open-angle glaucoma (OAG) and ocular hypertension (OHT) to improve our understanding of the causes and consequences of these diseases. Our first specific aim is diagnose OAG and OHT in an animal model. We are using a comprehensive, multiplatform approach that combines the latest imaging technologies with traditional ocular exams. Our second aim is to identify gene expression and metabolite profiles associated with OAG and OHT. We are conducting a transcriptomic (RNA-sequencing) and metabolomic study of glaucoma-relevant ocular tissues from a subset of individuals with OAG/OHT and from closely related individuals with health visual systems. For genes and metabolites associated with disease, we will examine the linked biological pathways relevant for cell death and inflammation; pathways implicated in human glaucoma, a leading cause of blindness globally. To our knowledge, we are the first to unite OAG status with the transcriptomics and metabolomics of affected ocular tissues originating from the same samples. Furthermore, we accomplish this in an exceptional animal model with naturally occurring disease. Our research will provide new foundational knowledge concerning the biology and pathophysiology of glaucoma, essential data for understanding this diverse and multifaceted disease. With this information, we hope to improve early diagnostic tools, and identify druggable targets for disease treatments.